|Bid||0.00 x 1300|
|Ask||0.00 x 3000|
|Day's range||11.52 - 11.74|
|52-week range||7.99 - 14.10|
|Beta (5Y monthly)||1.42|
|PE ratio (TTM)||16.57|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
FibroGen's (FGEN) Evrenzo (roxadustat) wins second approval in Japan for treating anemia caused by chronic kidney disease in non-dialysis-dependent patients.
Ironwood (IRWD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Matinas BioPharma (MTNB) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.